TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study
We Recommend
Disclosures
<p>Nothing to disclose</p>
New at TCTMD? Register today!
Enter the email you used to register to reset your password.